STAR-0215, a potent and long-acting MAb plasma kallikrein inhibitor for the treatment of HAE Nov. 8, 2021
New AAV/CRISPR strategy corrects complex genetic defects in a severe hemophilia B model Oct. 29, 2021
Phase II trial of roxadustat for chemotherapy-induced anemia meets primary efficacy endpoint Aug. 25, 2021
RSS